fda bpc-157 category 2 bulk drug substance compounding list Industry Update: Interim 503A and 503B Bulks Lists New Revisions Exciting news for peptides coming
Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Peptide Reclassification 2026: What It Means for Providers THE PCCA BLOG FDA Guidance Explained: Compounding with Bulk Dru
Pay in 4 interest-free payments of $5.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



